$DARE News Article - Dar Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women's Health Product Candidates through Key Catalysts
https://marketwirenews.com/news-releases/dar-...17712.html